Skip to content

Effectiveness of Homoeopathic treatment in Vitiligo for change in area, stage and spread of depigmented patch after treatment for 1 year

Effectiveness of Individualized Homoeopathic medicine (IH) and Arsenic Sulphuratum Flavum (ASF) in LM Potency in Vitiligo-A Single blind, Randomized, Comparative, Parallel group study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091687
Enrollment
154
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Individualized Homoeopathic medicine for 12 months: Homoeopathic medicine after repertorization of totality of symptoms Control Intervention1: Arsenic Sulphuratum Flavum for 12 months:

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Vitiligo lesion (1 or more) on any part of the body. 2. At least one patch to be more than 3cm in length and 3cm in width. 3. Patients of 18 year or more age group and both sex. 4. Patient giving written consent for study and photographic evidence

Exclusion criteria

Exclusion criteria: Patients on any other (allopathic/ ayurvedic/ naturopathic) treatment either topical or systemic for Vitiligo. Patient on laser or Phototherapy treatment for Vitiligo lesion. Patient on treatment with immune-modulating oral medications for other NCD or systemic illnesses. Patient suffering with other skin conditions (like dermatophytosis, scabies, ringworm, eczema etc.) Patients with hypothyroidism, or vitamin B 12 deficiency(below 200 pg/mL). Pregnant women

Design outcomes

Primary

MeasureTime frame
Change in Vitiligo European Task Force (VETF) scaleTimepoint: At baseline and every month till 12 month

Secondary

MeasureTime frame
Change in 1) Vitiligo Quality of life (VitiQoL) 2) Stigma Scale for Chronic Illnesses 8-item version (SSCI-8) 3) Laboratory parameters of Anti tyrosinase antibodies and Alpha Melanocyte Stimulating Hormone.Timepoint: VitiQoL, SSCI-8 at baseline,one month interval till 12 months Laboratory parameters at baseline, 6 month and 12 month

Countries

India

Contacts

Public ContactDr Divya Taneja

Central Research Institute (Homoeopathy) under Central Council for Research in Homoeopathy

drrenu3011@gmail.com09140570079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026